What is Amanda Lezanski-Gujda's NPI number?

Amanda Lezanski-Gujda's National Provider Identifier (NPI) is 1760809891, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Amanda Lezanski-Gujda's specialty?

Amanda Lezanski-Gujda is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Amanda Lezanski-Gujda located?

Amanda Lezanski-Gujda's practice location on file with NPPES is 6849 Old Dominion Dr Ste 450, Mc Lean, VA 22101-3718.

What is Amanda Lezanski-Gujda's phone number?

The practice phone number listed in the NPPES registry for Amanda Lezanski-Gujda is (703) 356-5111.

Does Amanda Lezanski-Gujda accept Medicare?

Amanda Lezanski-Gujda is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Amanda Lezanski-Gujda's NPI active?

Yes — Amanda Lezanski-Gujda's NPI (1760809891) is active in the NPPES registry as of the last update on 2023-01-24.

IndividualActiveAccepts Medicare

Amanda Lezanski-Gujda, D.O.

NPI 1760809891 · Dermatology Physician · Mc Lean, VA

Amanda Lezanski-Gujda, D.O. is a Dermatology Physician provider in Mc Lean, VA (NPI 1760809891).

Provider details

NPI number: 1760809891
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: D.O.
Sex: Female
Sole proprietor: No
License: 0102204303 (VA)

Practice location

6849 Old Dominion Dr Ste 450

Mc Lean, VA 22101-3718

Phone: (703) 356-5111

Street-level locationGet directions

More VA providers

Mailing address

6849 Old Dominion Dr Ste 450

Mc Lean, VA 22101-3718

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense 0102204303 (VA)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(62/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
12 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
536 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	189	$7
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	74	$95
New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More99203	50	$117
Destruction of Precancer Skin Growth, 1 Growth17000	49	$55
Biopsy of Related Skin Growth, First Growth11102	47	$104
Biopsy of Related Skin Growth, Each Additional Growth

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 6 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	26	17
Triamcinolone Acetonide	19	11
Nystatin	17	—
Mupirocin	16	—
Desonide	14	12
Clobetasol Propionate	13	11

Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do not include cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means no Part D record, never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$276 across 13 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2014-03-26
Last updated: 2023-01-24
Certified: 2023-01-24

Frequently asked questions

What is Amanda Lezanski-Gujda's NPI number?: Amanda Lezanski-Gujda's National Provider Identifier (NPI) is 1760809891, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Amanda Lezanski-Gujda's specialty?: Amanda Lezanski-Gujda is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Amanda Lezanski-Gujda located?: Amanda Lezanski-Gujda's practice location on file with NPPES is 6849 Old Dominion Dr Ste 450, Mc Lean, VA 22101-3718.
What is Amanda Lezanski-Gujda's phone number?: The practice phone number listed in the NPPES registry for Amanda Lezanski-Gujda is (703) 356-5111.
Does Amanda Lezanski-Gujda accept Medicare?: Amanda Lezanski-Gujda is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Amanda Lezanski-Gujda's NPI active?: Yes — Amanda Lezanski-Gujda's NPI (1760809891) is active in the NPPES registry as of the last update on 2023-01-24.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	189	$7
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	74	$95
New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More99203	50	$117
Destruction of Precancer Skin Growth, 1 Growth17000	49	$55
Biopsy of Related Skin Growth, First Growth11102	47	$104
Biopsy of Related Skin Growth, Each Additional Growth

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 6 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	26	17
Triamcinolone Acetonide	19	11
Nystatin	17	—
Mupirocin	16	—
Desonide	14	12
Clobetasol Propionate	13	11

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$276 across 13 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments